share_log
Reuters ·  May 6 08:30
NRX Pharmaceuticals Inc - Company Plans to Seek Accelerated Approval of NRX-101 for Use in Patients With Bipolar Depression at Risk of Akathisia
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment